SOD3-overexpressing MSCs specifically prevented the development of psoriasis in a mouse model of imiquimod (IMQ)-induced psoriasis-like inflammation via the inhibition of the TLR7/MAPKs/NF-κB axis and the activation of the adenosine receptor [214]. Here, SOD3 is linked to psoriasis.